Share This Page
Drug Price Trends for NDC 59762-3717
✉ Email this page to a colleague
Average Pharmacy Cost for 59762-3717
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| TRIAZOLAM 0.125 MG TABLET | 59762-3717-09 | 0.29374 | EACH | 2025-03-19 |
| TRIAZOLAM 0.125 MG TABLET | 59762-3717-09 | 0.23951 | EACH | 2025-02-19 |
| TRIAZOLAM 0.125 MG TABLET | 59762-3717-09 | 0.22189 | EACH | 2025-01-22 |
| TRIAZOLAM 0.125 MG TABLET | 59762-3717-09 | 0.25381 | EACH | 2024-12-18 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 59762-3717
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for the Drug NDC: 59762-3717
Introduction to National Drug Codes (NDCs)
The National Drug Code (NDC) is a unique, three-segment number that serves as the FDA’s identifier for drugs. For the NDC 59762-3717, which corresponds to Triazolam tablets, understanding the broader context of the pharmaceutical market and the specific mechanisms of pricing is crucial.
Understanding the NDC Directory
The FDA's NDC Directory is a comprehensive resource that contains information on all listed drugs in their final marketed form, including prescription, over-the-counter, approved, and unapproved drugs. This directory is updated daily and includes data elements such as the Drug Enforcement Administration schedule and pharmacological class[1][2].
Drug Details: Triazolam
Triazolam, identified by the NDC 59762-3717, is a prescription drug used for the short-term treatment of insomnia in adults, typically for 7 to 10 days. It is classified as a Schedule IV controlled substance under the DEA[4].
Pricing Mechanisms
Average Manufacturer Price (AMP) and Unit Rebate Amount (URA)
For drugs covered under the Medicaid Drug Rebate Program, the 340B ceiling price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure. This price is then adjusted by the package size and case pack size to determine the final ceiling price[2].
Example Calculation
To project prices for Triazolam (NDC 59762-3717), consider the following hypothetical example:
- AMP: $50 per unit
- URA: $10 per unit
- Package Size: 30 units
- Case Pack Size: 10 packages
[ \text{340B Ceiling Price} = (\text{AMP} - \text{URA}) \times \text{Package Size} \times \text{Case Pack Size} ] [ \text{340B Ceiling Price} = (50 - 10) \times 30 \times 10 = \$12,000 ]
This calculation provides a baseline for the ceiling price, but actual market prices can vary based on various factors including market demand, competition, and regulatory changes.
Market Analysis
Market Size and Growth Projections
The US pharmaceutical market is projected to grow significantly, from $846.72 billion in 2022 to $1.28 trillion by 2030, with a CAGR of 5.36%. This growth is driven by factors such as rising pharmaceutical production capacity, greater approvals of generic drugs, and escalating R&D investments[2].
Competition and Market Demand
Triazolam faces competition from other insomnia treatments, both prescription and over-the-counter. The demand for the drug can be influenced by factors such as the prevalence of insomnia, the effectiveness of the drug, and the availability of alternative treatments.
Regulatory Changes
Changes in regulatory policies, such as updates to the Medicaid Drug Rebate Program or new FDA guidelines, can impact pricing. For instance, any changes in the DEA scheduling or FDA approval processes could affect the market dynamics of Triazolam[2].
Technological Advancements
The adoption of AI and other technological advancements can reduce development and manufacturing costs, potentially leading to lower prices. However, for a drug like Triazolam, which is already established, the impact of such advancements might be more on the manufacturing efficiency rather than the price[2].
Price Projections
Historical Pricing Data
Reviewing historical pricing data from the NDC Directory and other sources can provide insights into price trends and potential future adjustments. For Triazolam, historical data would show any price fluctuations over time and help in predicting future price movements.
Market Demand and Competition
Given that Triazolam is a well-established drug with a specific use case, its price might be more stable compared to newer drugs. However, the presence of generic versions or alternative treatments could influence pricing strategies.
Regulatory and Technological Factors
Any regulatory changes or technological advancements that reduce production costs or improve efficiency could lead to price adjustments. For example, if new manufacturing technologies reduce the cost of producing Triazolam, this could result in lower prices for the consumer.
Key Takeaways
- NDC Directory: A critical resource for tracking and pricing drugs, updated daily by the FDA.
- Market Trends: The US pharmaceutical market is growing, with significant contributions from both small molecule drugs and biologics.
- Pricing Mechanisms: AMP and URA are key in calculating ceiling prices for covered outpatient drugs.
- Market Growth: The US pharmaceutical market is projected to grow significantly by 2030.
- Price Projections: Historical data, regulatory changes, market demand, and technological advancements influence price projections.
Industry Outlook
The life sciences industry, including pharmaceuticals, is poised for significant transformation in 2025, driven by digital advancements and scientific innovations. Despite competitive pressures, most global life sciences executives are optimistic about the future, with a focus on personalized medicine, genomics, and biomarkers. These advances are expected to improve efficacy and reduce side effects, which could impact the pricing and demand for drugs like Triazolam[5].
Quotes from Industry Experts
"Personalized medicine is a key area of focus for us. With advances in genomics and biomarkers, we can provide patients with more precise treatment options. This not only improves efficacy but also significantly reduces side-effects, allowing patients to have a better treatment experience," said a senior vice president of a small German pharma company[5].
Illustrative Statistics
- The US pharmaceutical market is projected to grow from $846.72 billion in 2022 to $1.28 trillion by 2030, with a CAGR of 5.36%[2].
- The biopharma market size was estimated to be over US$400 billion in 2024, with a projected CAGR of 7.56% between 2024 and 2029[3].
Highlight
"The integration of technologies like gen AI and the increased use of data are expected to boost operational efficiencies and drive breakthrough innovations. As companies adapt to this evolving landscape, their ability to implement new initiatives will be crucial for differentiation and market expansion." - Deloitte Insights[5]
Key Takeaways
- Market Analysis: Understanding the market dynamics, including competition and demand, is crucial for price projections.
- Pricing Mechanisms: AMP and URA play a significant role in determining the ceiling prices for covered outpatient drugs.
- Regulatory and Technological Factors: Changes in regulations and technological advancements can impact pricing.
- Industry Outlook: The life sciences industry is optimistic about the future, with a focus on personalized medicine and technological innovations.
FAQs
Q: What is the NDC code and how is it used? A: The National Drug Code (NDC) is a unique, three-segment number that serves as the FDA’s identifier for drugs. It is used for tracking, pricing, and regulatory compliance of pharmaceutical products in the U.S. market[1][2].
Q: How is the 340B ceiling price calculated for a drug like Triazolam? A: The 340B ceiling price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure, then adjusting by the package size and case pack size[2].
Q: What factors influence price projections for pharmaceuticals? A: Historical pricing data, regulatory changes, market demand, competition, and technological advancements influence price projections for pharmaceuticals[2].
Q: How does the FDA's NDC Directory impact the pricing of drugs? A: The FDA's NDC Directory provides critical information on listed drugs, including their marketing start and end dates, which can affect their pricing and availability in the market[1].
Q: What are the key trends expected in the life sciences industry in 2025? A: The life sciences industry is expected to see significant transformation driven by digital advancements, personalized medicine, and technological innovations. Key trends include a focus on genomics, biomarkers, and AI/ML technologies[3][5].
More… ↓
